Vaccine bus at the Allianz Arena again

Read article contents
Increase size

FC Bayern, in cooperation with the City of Munich, will once again offer visitors to the Allianz Arena the chance to get a COVID-19 vaccine without appointment at the home game against Hertha Berlin on Saturday (kick-off 18:30 CEST). As was the case for the pre-season friendly against Borussia Mönchengladbach and the Allianz FC Bayern Team Presentation, a mobile vaccine centre will be on the Esplanade from 15:30 until 18:30. People over the age of 16 are able to get vaccinated.

Second doses also possible

The bus will be in a central position on the Esplanade on the way from the train station to the stadium, where the Paulaner Garten is normally located. An appointment is not required, but prior registration through BayIMCO (www.impfzentren.bayern) would be appreciated to speed up the process on site, but is not mandatory. Depending on availability, there will be mRNA vaccines (e.g. BioNTech) and vector vaccines (e.g. Johnson & Johnson) offered, with the person free to choose. Second doses are also possible as long as the minimum gap between the first vaccination is observed. This is three weeks for BioNTech, four for Moderna, four for AstraZeneca cross-vaccination (first dose AstraZeneca, second mRNA) and nine for AstraZeneca. Evidence of the first vaccination (yellow vaccination certificate or vaccination certificate) is required. People who do not have their primary residence in Munich can also be vaccinated.

A valid identification document (identity card or passport) and, if available, the yellow vaccination certificate must be brought to the vaccination. It is important to note that this vaccination does not count as proof of the so-called 3G status (evidence of a test, vaccination or recovery) for stadium admission, as the required vaccine protection is only valid 15 days after the final required dose.

FC Bayern and the City of Munich were pleased by the results of the last two vaccine campaigns outside the Allianz Arena:

Share this article

Related news